Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Celsius Resources Limited Capital/Financing Update 2014

Feb 27, 2014

10450_rns_2014-02-27_1970dadd-9a85-4eaa-a177-4b1d3afe4b9b.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

28 February 2014

The Manager Announcements Company Announcements Office Australian Stock Exchange Limited PO Box H224 Australia Square SYDNEY NSW 2000

Dear Sir/Madam,

Blumont Funding Advance

Appendix 3B and Cleansing Notice

The Company is pleased to advise that it has made its third drawing under the Blumont facility and has now raised, and in return has issued, that number of Convertible Notes to Blumont with an aggregate face value of A$1,000,000.

Under the facility the Company has the ability to draw down a further additional amount of A$1,500,000 in total as and when required.

Please find attached a Cleansing Notice and Appendix 3B which provides for the issue of the Convertible Notes.

Yours faithfully,

==> picture [111 x 43] intentionally omitted <==

Ranko Matic Non- Executive Director Company Secretary

28 February 2014

The Manager Companies Announcements Office Australian Securities Exchange

NOTICE UNDER SECTION 708A(12C)(e)

This notice is given by Celsius Coal Limited (ACN 009 162 949) ( Celsius or the Company ) (ASX:CLA) pursuant to Section 708A(12C)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ).

As announced on 7 February 2013, Celsius has in place a strategic financing arrangement ( Arrangement ) with Blumont Group Limited, a Singapore-based company listed on the Singapore Exchange ( Blumont ), to the value of A$10m.

The key elements of the Arrangement include:

  • Share Placement – a placement of 227,272,727 fully paid ordinary shares in the capital of Celsius ( Shares ) to Blumont for an aggregate subscription of A$5 million (at an issue price of A$0.022 per share) ( Share Placement ). The Share Placement was completed in March this year.

  • Convertible Note Facility – the Company may drawdown between A$3 million to A$5 million (at the Company’s option) after 30 June 2013 from Blumont and in return Blumont will be issued Convertible Notes from the Company ( Convertible Notes ) ( Convertible Note Facility ). The first A$3 million in aggregate is to be drawn down prior to 31 December 2013. The Convertible Notes will carry interest at the rate of 12.5% per annum payable halfyearly. The Convertible Notes will be convertible into Shares based at the 20 trading day VWAP prior to conversion and subject to a floor price of A$0.025 per Share and a cap of A$0.030 per Share. Blumont will have the right to call conversion anytime after issuance and the Company will have the right to call conversion anytime from 12 months after issuance, with any conversion subject to the condition that it does not result in a voting interest exceeding 20% of Celsius. The first drawing under this facility was made on 26 September 2013, where the Company raised, and in return issued, that number of Convertible Notes to Blumont with an aggregate face value of $2,000,000. The second drawing was made on 5 December 2013, where the Company raised, and in return, issued, that number of Convertible Notes to Blumont with an aggregate face value of $500,000.

  • Strategic Alliance – Blumont and Celsius will cooperate to review other potential projects in Central Asia. Blumont will nominate one director to the board of Celsius (subject to it maintaining a shareholding in excess of 10%) and Celsius will nominate Alexander Molyneux to the board of Blumont.

Subsequently, the Company wishes to advise that it has made its third drawing under the facility and has now raised, and in return has issued, that number of Convertible Notes to Blumont with an aggregate face value of A$1,000,000.

The Company hereby gives notice that:

  • (a) the Convertible Notes were issued without a disclosure document under Part 6D.2 of the Corporations Act; and

  • (b) this notice has been given in accordance with Section 708A(12C)(e) of the Corporations Act as inserted by Class Order [CO 10/322] (on-sale for convertible notes issued to wholesale investors).

1. EFFECT OF THE ISSUE ON THE COMPANY

  • (a) The intended use of the funds raised (A$1,000,000) will be allocated towards advancing the Company’s 2013/2014 exploration and development programme on its Uzgen Basin Coking Coal Project located in the Kyrgyz Republic and towards the review of other potential projects in Central Asia, together with its strategic partner, Blumont.

The current status of the Company’s 2013/2014 exploration and development programme is set out in its recent Quarterly Activities Report dated 31 January 2014.

A summary of the rights and liabilities attaching to the Convertible Notes issued to Blumont are set out in Section 2 below.

(b) The effect on the issued share capital of the Company on conversion of the Convertible Notes is set out in the table below. This is based on a floor price of $0.025 and does not account for any accrued interest.

Number
Shares currently on issue 2,011,471,247
Shares issued upon conversation of the previous issue of Convertible Notes1 100,000,000
Shares issued upon conversion of the current issue of Convertible Notes1 40,000,000
Total Shares on issue following conversion of the Convertible Notes 2,151,471,247

Notes:

  1. This is based on a floor price of $0.025 and does not account for any accrued interest under the Convertible Note Facility.

  2. Please note, the Company also has a total of 269,500,000 options, 927,000,000 performance shares and 25,000,000 performance rights on issue.

  3. The Company has the ability to issue additional Convertible Notes to the value of A$1.5m pursuant to the Convertible Note Facility by no later than 1 July 2023.

  4. (c) Blumont currently holds a total of 227,272,727 Shares equating to a voting power of 11.3% in the Company. On the basis that the Convertible Notes convert into Shares (excluding any accrued interest) and no other Shares are issued, Blumont’s voting power in the Company will increase to 17.1%. Based on these calculations, upon conversion, shareholders holdings would be diluted by 5.8%.

In the unlikely event that interest was to accrue per annum until July 2023, and as such no Convertible Notes are converted until maturity, this would equate to an additional $4.375m in accrued interest. However, in the event that

Convertible Notes are converted (in part) during this period, the overall amount of accrued interest will thereupon be reduced. In any event, Blumont will be prohibited from obtaining an overall voting interest in the Company exceeding 20%.

  • (d) Blumont is not a related party of the Company.

2. RIGHTS AND LIABILITIES ATTACHING TO THE CONVERTIBLE NOTES

The following is a summary of the rights and liabilities attaching to the Convertible Notes:

  • (a) Facility Limit

A$5,000,000.

(b) Minimum Drawdown

A$3,000,000 prior to 31 December 2013.

(c)

Term

Beginning 1 July 2013 and ceasing on the earlier of:

  • (i) that date which is ten (10) years from the date of issue of the first Convertible Note; and

  • (ii) that date upon which an event of default occurs in accordance with the terms of the Convertible Note Facility ( Repayment Date ).

(d) Interest

  • (i) 12.5% per annum payable in 6 monthly instalments (on the 6 month and 12 month anniversary of the issue date).

  • (ii) Prior to each interest payment date, the noteholder ( Noteholder ) may elect for interest to be paid in cash or Shares, but if no election is made, the Company may make the determination on the Noteholder’s behalf.

(e) Security

Unsecured and will rank equally with all other unsecured creditors of the Company.

(f) Conversion

  • (i) The Noteholder will be entitled to convert all or a portion of the Convertible Notes together with any accrued interest (if applicable) into Shares by delivering a conversion notice to the Company at any time prior to the Repayment Date.

  • (ii) The Company will apply for quotation of the Shares issued on conversion of the Convertible Notes. The Convertible Notes themselves will not be quoted on the ASX.

  • (iii) Shares issued on conversion (including in respect of accrued interest) will rank equally with all other Shares on issue in the Company.

  • (iv) Each Convertible Note and, where applicable, any accrued interest will convert into Shares at the following conversion price:

  • (A) with respect to the face value of each Convertible Note, the 20 trading day VWAP, subject to a floor price of $0.025 per Share and a cap of $0.03 per Share; and

  • (B) in respect of any accrued interest, $0.0275 per Share;

  • (v) Following the date which is 12 months from the date the Minimum Drawdown has occurred, the Company may elect for the Noteholder to convert any or a portion of the outstanding Convertible Notes (and accrued interest) into Shares.

(g) Voting Power Restriction

The Noteholder will not be entitled to convert any Convertible Notes (or accrued interest) into Shares to the extent that the voting power of the Noteholder would exceed 20% in the Company.

(h) Transferability

Convertible Notes can be transferred but will not be quoted on ASX.

(i)

Bonus Issues

The Convertible Notes will entitle the Noteholder to participate in any pro-rata bonus issues undertaken by the Company, such additional Shares to be issued to the Noteholder (the subject of the bonus issue) following the conversion of the respective Convertible Notes.

(j) Reconstructions

In the event of a reconstruction of the capital of the Company, such as a consolidation, subdivision, reduction, return or scheme of arrangement, a proportionate adjustment will be made to the Convertible Notes on that same basis.

(k) Participation in New Issues

A Convertible Note does not confer any rights to participate in new issues of Shares without converting that Convertible Note.

(l) Redemption

Any Convertible Notes outstanding at the maturity date, and which are not then subject to a conversion notice, are to be redeemed. The redemption payment is to be in Australian dollars, inclusive of capitalised interest.

3. RIGHTS AND LIABILITIES ATTACHING TO THE SHARES ISSUED ON CONVERSION

The following is a summary of the more significant rights attaching to Shares. This summary is not exhaustive and does not constitute a definitive statement of the rights and liabilities of shareholders of the Company ( Shareholders ). To obtain such a statement, persons should seek independent legal advice.

Full details of the rights attaching to Shares are set out in the Company’s Constitution, a copy of which is available for inspection at the Company’s registered office during normal business hours.

(a) General meetings

Shareholders are entitled to be present in person, or by proxy, attorney or representative to attend and vote at general meetings of the Company.

Shareholders may requisition meetings in accordance with Section 249D of the Corporations Act and the Constitution.

(b) Voting rights

Subject to any rights or restrictions for the time being attached to any class or classes of Shares, at general meetings of Shareholders or classes of Shareholders:

  • (i) each Shareholder entitled to vote may vote in person or by proxy, attorney or representative;

  • (ii) on a show of hands, every person present who is a Shareholder or a proxy, attorney or representative of a Shareholder has one vote; and

  • (iii) on a poll, every person present who is a Shareholder or a proxy, attorney or representative of a Shareholder shall, in respect of each fully paid Share held by him, or in respect of which he is appointed a proxy, attorney or representative, have one vote for the Share, but in respect of partly paid Shares shall have such number of votes as bears the same proportion to the total of such Shares registered in the Shareholder’s name as the amount paid (not credited) bears to the total amounts paid and payable (excluding amounts credited).

(c) Dividend rights

Subject to the rights of any preference Shareholders and to the rights of the holders of any shares created or raised under any special arrangement as to dividend, the Directors may from time to time declare a dividend to be paid to the Shareholders entitled to the dividend which shall be payable on all Shares according to the proportion that the amount paid (not credited) is of the total amounts paid and payable (excluding amounts credited) in respect of such Shares.

The Directors may from time to time pay to the Shareholders any interim dividends as they may determine. No dividend shall carry interest as against the Company. The Directors may set aside out of the profits of the Company any amounts that they may determine as reserves, to be applied at the discretion of the Directors, for any purpose for which the profits of the Company may be properly applied.

Subject to the ASX Listing Rules and the Corporations Act, the Company may, by resolution of the Directors, implement a dividend reinvestment plan on such terms and conditions as the Directors think fit and which provides for any dividend which the Directors may declare from time to time payable on Shares which are participating Shares in the dividend reinvestment plan, less any amount which the Company shall either pursuant to the Constitution or any law be entitled or obliged to retain, be applied by the Company to the payment of the subscription price of Shares.

(d) Winding-up

If the Company is wound up, the liquidator may, with the authority of a special resolution of the Company, divide among the shareholders in kind the whole or any part of the property of the Company, and may for that purpose set such value as he considers fair upon any property to be so divided, and may determine how the division is to be carried out as between the Shareholders or different classes of Shareholders.

The liquidator may, with the authority of a special resolution of the Company, vest the whole or any part of any such property in trustees upon such trusts for the benefit of the contributories as the liquidator thinks fit, but so that no Shareholder is compelled to accept any Shares or other securities in respect of which there is any liability.

(e) Shareholder liability

As the Shares under the Prospectus are fully paid shares, they are not subject to any calls for money by the Directors and will therefore not become liable for forfeiture.

(f)

Transfer of Shares

Generally, Shares are freely transferable, subject to formal requirements, the registration of the transfer not resulting in a contravention of or failure to observe the provisions of a law of Australia and the transfer not being in breach of the Corporations Act or the ASX Listing Rules.

(g)

Variation of rights

Pursuant to Section 246B of the Corporations Act, the Company may, with the sanction of a special resolution passed at a meeting of Shareholders vary or abrogate the rights attaching to Shares.

If at any time the share capital is divided into different classes of Shares, the rights attached to any class (unless otherwise provided by the terms of issue of the shares of that class), whether or not the Company is being wound up, may be varied or abrogated with the consent in writing of the holders of three-quarters of the issued shares of that class, or if authorised by a special resolution passed at a separate meeting of the holders of the shares of that class.

(h)

Alteration of Constitution

The Constitution can only be amended by a special resolution passed by at least three quarters of Shareholders present and voting at the general meeting. In addition, at least 28 days written notice specifying the intention to propose the resolution as a special resolution must be given.

4. COMPLIANCE WITH REGULAR REPORTING AND DISCLOSURE OBLIGATIONS

The Company is a “disclosing entity” (as defined in section 111AC of the Corporations Act) for the purposes of the Corporations Act and, as such, is subject to regular reporting and disclosure obligations. Specifically, like all listed companies, the Company is required to continuously disclose any information it has to the market which a reasonable person would expect to have a material effect on the price or the value of the Company’s securities.

The Company, as a disclosing entity under the Corporations Act states that:

  • (a) it is subject to regular reporting and disclosure obligations;

  • (b) copies of documents lodged with the ASIC in relation to the Company (not being documents referred to in section 1274(2)(a) of the Corporations Act) may be obtained from, or inspected at, the offices of the ASIC; and

  • (c) it will provide a copy of each of the following documents, free of charge, to any person on request:

  • (A) the annual financial report most recently lodged by the Company with the ASIC;

  • (B) any half-year financial report lodged by the Company with the ASIC after the lodgement of the annual financial report referred to in (i) and before the lodgement of this notice with the ASIC; and

  • (C) any continuous disclosure documents given by the Company to ASX in accordance with the ASX Listing Rules as referred to in section 674(1) of the Corporations Act after the lodgement of the annual financial report referred to in (i) and before the lodgement of this notice with the ASIC.

Copies of all documents lodged with the ASIC in relation to the Company can be inspected at the registered office of the Company during normal office hours.

Details of documents lodged by the Company with ASX since the date of lodgement of the Company’s latest annual financial report and before the lodgement of this notice with the ASIC are set out in the table below:

Date Description of Announcement
11/02/2014 Uzgen Basin Licences Extended
31/01/2014 Quarterly Cashflow Report
31/01/2014 Quarterly Activities Report
30/01/2014 Hartleys Research Report – January 2014
29/01/2014 Fox Davies Capital – Mining Flashnote on Coal Quality
29/01/2014 Investor Presentation – January 2014
22/01/2014 Quality Results for Kokkia Improve Overall Coking Properties
17/01/2014 Updated Announcement – Analysis of Coking Coal Potential
Date Description of Announcement
16/01/2014 Fox Davies Capital – Mining Flashnote
13/01/2014 Analysis Confirms Coking Coal Potential of Uzgen Basin
17/12/2013 New Infrastructure Options for Coal transport
12/12/2013 Change in Directors Interest Notice - App 3Y (x 3)
12/12/2013 Appendix 3B
11/11/2013 Company Interview – Strong Outlook for 2014
5/12/2013 Appendix 3B and Cleansing Notice
13/11/2013 Results of Annual General Meeting
8/11/2013 Fox-Davies Capital initiates research coverage
31/10/2013 Quarterly Cashflow Report
31/10/2013 Quarterly Activities Report
24/10/2013 Appendix 3B
24/10/2013 Completion of 2013 Drilling Program – Uzgen Basin
14/10/2013 Notice of Annual General Meeting/Proxy Form
14/10/2013 Annual Report to Shareholders
11/10/2013 Release from escrow
9/10/2013 Alex Molyneux to join Blumont Group as Shareholder-Chairman
1/10/2013 Exploration Update – Kokkia drill hole record coal thickness
27/09/2013 Updated Investor Presentation – October 2013

ASX maintains files containing publicly available information for all listed companies. The Company’s file is available for inspection at ASX during normal office hours.

The announcements are also available through the Company’s website www.celsiuscoal.com.au.

5. INFORMATION EXCLUDED FROM CONTINUOUS DISCLOSURE NOTICES

The market is fully informed of the Company’s activities and the Company is not aware of any other information that:

  • (a) has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

  • (b) is information that investors and their professional advisers would reasonably require for the purposes of making an informed assessment of:

  • (i) the assets and liabilities, financial position and performance, profits and losses and prospects of the body; and

(ii) the right and liabilities attaching to the Convertible Notes being offered.

Yours faithfully,

==> picture [115 x 44] intentionally omitted <==

Ranko Matic Non-Executive Director Company Secretary

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Celsius Coal Limited

ABN

95 009 162 949

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued or to Convertible Notes be issued 2 Number of[+] securities issued or 10 to be issued (if known) or maximum number which may be issued 3 Principal terms of the Unlisted Convertible Notes with a face value +securities (e.g. if options, of $100,000 each. Full terms as per attached exercise price and expiry date; if Annexure 2. partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

4
Do the+securities rank equally
in all respects from the+issue
date with an existing+class of
quoted+securities?
If the additional+securities do
not rank equally, please state:
 the date from which they do
 the extent to which they
participate
for
the
next
dividend, (in the case of a
trust,
distribution)
or
interest payment
 the extent to which they do
not rank equally, other than
in
relation
to
the
next
dividend,
distribution
or
interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
6a
Is the entity an+eligible entity
that
has
obtained
security
holder approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
6c
Number of+securities issued
without security holder approval
under rule 7.1
N/A
1,000,000
The funds raised are to be used in the
development of the Group’s projects as well
as provide for any working capital required.
Yes
13 November 2013
Nil
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

6d
Number of+securities issued
with security holder approval
under rule 7.1A
6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which
valuation
of
consideration was released to
ASX Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
Nil
n/a
Nil

n/a
n/a
Under 7.1 – 296,646,459
Under 7.1A – 201,097,640
27 February 2014
  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

8
Number
and
+class
of
all
+securities
quoted
on
ASX
(_including_the
+securities in
section 2 if applicable)
9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the
+securities in
section 2 if applicable)
Number +Class
2,010,976,397 Ordinary Fully Paid
Shares
Number +Class
155,000,000
5,000,000
20,000,000
2,000,000
205,400,000
205,400,000
205,400,000
155,400,000
155,400,00
25,000,000
Options exercisable
at 1 cent each and
expiring on 31 March
2014
Class A Options
exercisable at 2 cents
each and expiring on
31 October 2014
Class
C
Options
exercisable at 2 cents
each and expiring 21
February 2015
Employee
Options
exercisable at 2 cents
each and expiring 21
February 2016
Class A Performance
Shares
Class B Performance
Shares
Class C Performance
Shares
Class D Performance
Shares
Class E Performance
Shares
Class B Performance
Rights
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Appendix 3B New issue announcement

10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
art 2 - Pro rata issue
11
Is
security
holder
approval
required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities
will be offered
14
+Class of+securities to which the
offer relates
25,000,000
15,000,000
15,000,000
15,000,000
5,000,000
35
12,500,000
Options exercisable
at
$0.025
and
expiring 10/4/16
Options exercisable
at
$0.020
and
expiring 20/5/16
Options exercisable
at
$0.035
and
expiring 20/5/16
Options exercisable
at
$0.050
and
expiring 20/5/16
Employee
Options
exercisable at 2 cents
each and expiring 24
October 2016
Convertible
notes
with a face value of
$100,000
each
convertible at the 20
day VWAP
Options exercisable
at
$0.020
and
expiring12/12/16
No dividend policy established as the
Company is still in exploration phase
Not applicable

Part 2 - Pro rata issue

  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

15 +Record
date
to
determine
entitlements
16 Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17 Policy for deciding entitlements
in relation to fractions
18 Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing
date
for
receipt
of
acceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting fee
or commission
22 Names of any brokers to the
issue
23 Fee or commission payable to the
broker to the issue
24 Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25 If the issue is contingent on
security holders’ approval, the
date of the meeting
26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B New issue announcement

27 If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do security holders sell
their entitlements_in full_through
a broker?
31 How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
32 How do security holders dispose
of their entitlements (except by
sale through a broker)?

33 +Issue date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one ) (a) +Securities described in Part 1

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

38 Number of+securities for which
+quotation is sought
39 +Class of+securities for which
quotation is sought
40 Do the+securities rank equally in
all respects from the+issue date
with an existing+class of quoted
+securities?
If the additional+securities do not
rank equally, please state:
 the date from which they do
 the extent to which they
participate
for
the
next
dividend, (in the case of a
trust, distribution) or interest
payment
 the extent to which they do
not rank equally, other than in
relation to the next dividend,
distribution
or
interest
payment
  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Appendix 3B New issue announcement

  • 41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)

Number +Class

42 Number and +class of all +securities quoted on ASX ( including the[+] securities in clause 38)

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B New issue announcement

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [102 x 39] intentionally omitted <==

Sign here:

............................................................ Date: 27/2/2014 (Non-Executive Director & Company secretary)

Print name: Ranko Matic

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

  • Insert number of fully paid[+] ordinary 1,752,703,670 securities on issue 12 months before the + issue date or date of agreement to issue Add the following: 227,272,727 (issued 11/3/13) • Number of fully paid[+] ordinary securities 5,000,000 (options exercised 6/8/13) issued in that 12 month period under an exception in rule 7.2 5,000,000 (options exercised 9/9/13)

  • • Number of fully paid[+] ordinary securities 5,000,000 (options exercised 24/10/13) issued in that 12 month period with shareholder approval 16,000,000 (Perf Rights converted 12/12/13)

  • • Number of partly paid[+] ordinary securities that became fully paid in that 12 month period

  • Note: • Include only ordinary securities here – other classes of equity securities cannot be added

  • • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

  • • It may be useful to set out issues of securities on different dates as separate line items

  • Subtract the number of fully paid[+] ordinary Nil securities cancelled during that 12 month period “A” 2,010,976,397

  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 301,646,459
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
5,000,000 (options 24/10/2013)
“C” 5,000,000
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
301,646,459
Subtract“C”
Note: number must be same as shown in
Step 3
5,000,000
Total[“A” x 0.15] – “C” 296,646,459
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 2,010,976,397 Note: number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 201,097,640

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued Nil or agreed to be issued in that 12 month period under rule 7.1A

Notes:

  • This applies to equity securities – not just ordinary securities

  • • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • • It may be useful to set out issues of securities on different dates as separate line items

  • “E” Nil

  • See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
201,097,640
Subtract“E”
Note: number must be same as shown in
Step 3
Nil
Total[“A” x 0.10] – “E” 201,097,640
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 14

04/03/2013